Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Daiichi Sankyo
Express Scripts
Baxter
Federal Trade Commission
Fuji
AstraZeneca
Accenture
McKinsey

Generated: February 23, 2019

DrugPatentWatch Database Preview

EXTAVIA Drug Profile

« Back to Dashboard

Summary for Tradename: EXTAVIA
Patents:33
Applicants:1
BLAs:1
Suppliers: see list1

US Patents for EXTAVIA

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Novartis Pharms EXTAVIA interferon beta-1b INJECTABLE; SUBCUTANEOUS 125290 001 2009-08-14 ➤ Sign Up Pathologica LLC (San Francisco, CA) ➤ Sign Up RX search
Novartis Pharms EXTAVIA interferon beta-1b INJECTABLE; SUBCUTANEOUS 125290 001 2009-08-14 ➤ Sign Up Nova Molecular, Inc. (Montreal, CA) ➤ Sign Up RX search
Novartis Pharms EXTAVIA interferon beta-1b INJECTABLE; SUBCUTANEOUS 125290 001 2009-08-14 ➤ Sign Up Vereniging Voor Christelijk Wetenshappelikjk Onderwijs (Amsterdam, NL) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for EXTAVIA

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
CR 2016 00058 Denmark ➤ Sign Up PRODUCT NAME: DACLIZUMAB; REG. NO/DATE: EU/1/16/1107 20160705
93315 Luxembourg ➤ Sign Up PRODUCT NAME: PROCEDE DE TRAITEMENT DE LA SCLEROSE MULTIPLE - DACLIZUMAB; AUTHORISATION NUMBER AND DATE: EU/1/16/1107
16C1017 France ➤ Sign Up PRODUCT NAME: DACLIZUMAB; REGISTRATION NO/DATE: EU/1/16/1107 20160705
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Chubb
Colorcon
Merck
Healthtrust
Mallinckrodt
Queensland Health
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.